| 1 |
Kaswala DH, Lai M, Afdhal NH.Fibrosis Assessment in Nonalcoholic Fatty Liver Disease(NAFLD)in 2016 [J]. Dig Dis Sci, 2016, 61(5): 1356-1364.
|
| 2 |
Fouad SA, Esmat S, Omran D, et al.Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection[J]. World J Gastroenterol, 2012, 18(23): 2988-2994.
|
| 3 |
Chang PE, Goh GB, Ngu JH.Clinical applications, limitations and future role of transient elastography in the management of liver disease [J]. World J Gastrointest Pharmacol Ther, 2016, 7(1): 91-106.
|
| 4 |
Ebrahimi H, Naderian M, Sohrabpour AA.New Concepts on Pathogenesis, Diagnosis, and Targeting of Liver Fibrosis；A Review Article[J]. Middle East J Did Dis, 2016, 8: 166-178.
|
| 5 |
Mazzara S, Sinisi A, Cardaci A, et al.Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis[J]. PLoS One, 2015, 10(9): e0137927.
|
| 6 |
Gressner AM, Rizk M, Gao CF, et al.Potential novel biomarkers for monitoring the fibrogenic process in liver[J]. Arab J Gastroenterol, 2010, 10(4): s12-s16.
|
| 7 |
Liu L, Zhang J, Xie DH, et al.Advances of Hepatic Fibrosis-Associated Serological Markers in the View of Translational Medicine[J]. J Int Transl Med, 2016, 4(1): 28-35.
|
| 8 |
Soresi M, Giannitrapani L, Cervello M, et al.Non invasive tools for the diagnosis of liver cirrhosis[J]. World J Gastroenterol, 2014, 20(48): 18131-18150.
|
| 9 |
Ebrahimi H, Naderian M, Sohrabpour AA.New Concepts on Pathogenesis andDiagnosisof Liver Fibrosis；A Review Article[J]. Middle East J Dig Dis, 2016, 8(3): 166-178.
|
| 10 |
任俊杰，刘立新．MMPs/TIMPs介导的纤维消融平衡与肝纤维化的研究新进展[J/CD]．中华消化病与影像杂志(电子版)，2016，6(4): 175-179.
|
| 11 |
Walsh KM, Timms P, Campbell S, et al.Plasma levels of matrix metalloproteinase-2(MMP-2)and tissue inhibitors of metalloproteinases-1 and-2(TIMP-1 and TIMP-2)as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis[J]. Dig Dis Sci, 1999, 44(3): 624-630.
|
| 12 |
Ling H, Roux E, Hempel D, et al.Transforming growth factorβneutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.PLoS One, 2013, 8(1): e54499.
|
| 13 |
Mitchell SA, Willam PP, Herbert R, et al.Transforming Growth Factorβas a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer[J]. N Engl J Med, 1993, 328(22): 1592-1598.
|
| 14 |
Ahmed S, Abedel Haleema, Laila N. Mohamedb and Eman A. Elgohary.Role of fibroscan, TGF-b1, and YKL-40 in the detection of hepatic fibrosis in chronic hepatitis c patients with and without schistosomiasis[J]. Egyptian Liver Journal, 2015, 5(3): 47-53.
|
| 15 |
Mahmoud AA, Bakir AS, Shabana SS.Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD[J]. Saudi J Gastroenterol, 2012, 18(5): 327-333.
|
| 16 |
中华肝脏病学会肝纤维化学组．肝纤维化诊断及疗效评估共识[J]．药品评价，2007，4(4): 265-266.
|
| 17 |
Zhang B, Cai WM, Weng HL, et al.Diagnostic value of platelet derived growth factor-BB, transforming growth factor B1, matrix metalloproteinase-1 and tissue inhibitor matrix rnetalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis[J]. World J Gastroenterol, 2003, 9(11): 2490-2496.
|
| 18 |
Ktmaz C, Enderterzioglu E, Topalak O, et al.Serum transforming growth factor-B1 level in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C[J]. Eur Cytokine Netw, 2004, 15(2): 112-116.
|
| 19 |
Zhang BB, Cai WM, Weng HL, et al.Diagnostic value of platelet derived growth factor-BB, transforming growth factor-b1, matrixmetalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis[J]. World J Gastroenterol, 2003, 9(11): 2490-2496.
|
| 20 |
Mitsuko Hara, Tomokazu Matsuura, Soichi Kojima.TGF-βLAP Degradation Products, a Novel Biomarker and Promising Therapeutic Target for Liver Fibrogenesis[J]. Innovative Medicine, 2015, 317-325.
|
| 21 |
Toshima T, Shirabe K, Ikegami T, et al.A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein(WFA＋-M2BP), for assessing liver fibrosis[J]. J Gastroenterol, 2015, 50(1): 76-84.
|
| 22 |
Umemura T, Joshita S, Sekiguchi T, et al.Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis[J]. Am J Gastroenterol, 2015, 110(6): 857-864.
|
| 23 |
Tran A, Benzaken S, Saintpaul MC.Chondrex(YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease[J]. Eur J Gastroenterol Hepatol, 2000, 12(9): 989-993.
|
| 24 |
Saitou Y, Shiraki K, Yamanaka Y. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease[J]. World J Gastroenterol, 2005, 11(4): 476-481.
|
| 25 |
Lebensztejn DM, Skiba E, Werpachowska I, et al.Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B[J]. Adv Med Sci, 2007, 52: 120-124.
|
| 26 |
曹欣，关玉娟，陈美娟．慢性乙型肝炎病毒感染患者血清YK L-4 0水平与肝纤维化的临床分析[J]．肝脏，2016，21(1): 57-59.
|
| 27 |
Boers W, Aarrass S, Linthorst C, et alTranscriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor binding proteins[J]. J Biol Chem, 2006, 281(24): 16289-16295.
|
| 28 |
田小霞，秦桂秀，贠克明，等．肝纤维化患者肝组织中胰岛素样生长因子结合蛋白的表达及意义[J]．中华肝脏病杂志，2006，14(11): 858-860.
|
| 29 |
石永强，刘立新，张海燕，等．小鼠肝组织中胰岛素样生长因子结合蛋白相关蛋白1在肝纤维化发生及发展中的作用[J]．中华消化外科杂志，2010，9(5): 377-382.
|
| 30 |
Guo Y, Zhang Y, Zhang Q, et al.Insulin-like growth factor binding protein-related protein 1(IGFBPrP1)contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway[J]. Hepatol Int, 2015, 9(1): 130-141.
|
| 31 |
李媛，刘立新，张骞骞，等．IGFBPrP1对小鼠肝组织胶原含量的影响及其机制的研究[J]．中华肝胆外科杂志，2011，17(2): 146-149.
|
| 32 |
Zhang Y, Zhang QQ, Guo XH, et al.IGFBPrP1 induces liver fibrosis by inducing hepatic stellate cell activation and hepatocyte apoptosis via Smad2/3 signaling[J]. World J Gastroenterol, 2014, 20(21): 6523-6533.
|
| 33 |
许君君，刘立新，张骞骞，等．抗胰岛素样生长因子结合蛋白相关蛋白1对小鼠肝纤维化的保护作用[J]．中华肝脏病杂志，2009，17(6): 464-465.
|
| 34 |
刘立新，张骞骞，韩德五，等. IGFBP2、IGFBP6在TGF-β1活化的肝星状细胞中表达[J]．中国病理生理杂志，2008，24(12): 2481-2483.
|
| 35 |
Li XQ, Zhang QQ, Zhang HY, et al.Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4): 395-404.
|
| 36 |
Zhang HY, Zhang Y, Wang XH, et al.Value of IGFBPrP1 and contrast-enhanced ultrasound in liver fibrosis staging with rabbits[J]. Int J Clin Exp Med, 2017, 10(8): 11606-11615.
|